Research Associate in Paediatric Cancer Drug Resistance Mechanisms

This fixed-term Research Associate position at the University of Cambridge’s Department of Pathology offers an opportunity to contribute to groundbreaking research on drug resistance mechanisms in neuroblastoma, a rare and aggressive childhood cancer. Under the supervision of Professor Suzanne Turner, the successful candidate will focus on post-translational histone modifications and their role in therapeutic resistance, aiming to identify biomarkers for poor-prognosis patients. The project is funded by the Little Princess Trust and combines molecular biology, chromatin immunoprecipitation, and sequencing techniques. The role also involves mentoring PhD students and fostering an inclusive research environment. The position is ideal for postdoctoral scientists with a strong background in cancer biology and molecular techniques.

• Investigate mechanisms of drug resistance in neuroblastoma using advanced molecular biology techniques, including chromatin immunoprecipitation and sequencing.
• Develop novel biomarkers to identify high-risk paediatric cancer patients based on post-translational histone modifications.
• Conduct experimental research to explore therapeutic approaches targeting drug-resistant cancer cells.
• Supervise and mentor PhD students, providing guidance on research methodologies and project development.
• Collaborate with interdisciplinary research teams to translate findings into clinically applicable solutions.
• Contribute to the publication of research findings in high-impact scientific journals.
• Participate in departmental seminars, journal clubs, and internal research discussions.
• Maintain accurate records of experimental data and ensure compliance with laboratory protocols and safety regulations.